Health care is more than doctor visits; it’s a team effort. But most artificial intelligence-driven technologies built on patient data use only the information provided by physicians, omitting crucial input from nurses and rehabilitation therapists.
Enara Bio’s $32.5M Series B to support lead dark antigen program for GI cancers
Enara Bio has snagged $32.5 million in a Series B fundraise, backed in part by Pfizer’s venture arm, to help develop a preclinical pipeline of
October 4, 2024